Enantiomerically pure molybdenum imido alkylidene complexes were prepared that contain binaphtholate ligands substituted in the 3 and 3‘ positions with either phenyl ( 4; Mo(NAr)(CHCMe 2 Ph)[Ph](THF)) or 2,4,6-trimethylphenyl groups ( 5; Mo(NAr)(CHCMe 2 Ph)[Mes](THF); Ar = 2,6-i-Pr 2 C 6 H 3 ). Compound 5 was found to be an anti trigonal bipyramidal complex in an X-ray study. Asymmetric metatheses employing complex 5 were found to proceed to high conversion and to give high product % ee, while reactions that employed complex 4 were found to give lower conversion and lower % ee. One ring-closing reaction with 5 was shown to take place at a rate that was proportional to catalyst and substrate. Molybdacyclobutane complexes were observed in solution during ring-closing reactions. The molybdacyclobutane complex generated by treating 5 with ethylene was found to be a trigonal bipyramidal species which decomposed to yield some propylene; the metal-containing product or products of decomposition could not be identified. Molybdacyclobutane complexes were also formed upon adding ethylene to the analogous complex containing a 2,4,6-triisopropylphenyl-substituted binaphtholate ligand, or to 4 . The detection of propylene as a product of decomposition of the molybdacyclobutane complexes examined here suggests that a decomposition pathway that consists of β hydride rearrangement can compete with bimolecular decomposition of methylene complexes under some conditions.
No takes yet. Share an insight, caveat, or question.
Tsang et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: